Total Payments
$12,766
2024 Payments
$1,904
Companies
54
Transactions
920
Medicare Patients
7,690
Medicare Billing
$480,503
Payment Breakdown by Category
Food & Beverage$12,660 (99.2%)
Education$105.52 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,660 | 907 | 99.2% |
| Education | $105.52 | 13 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,134 | 162 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,745 | 84 | $0 (2024) |
| PFIZER INC. | $1,306 | 124 | $0 (2024) |
| Amgen Inc. | $864.50 | 59 | $0 (2024) |
| ABBVIE INC. | $752.36 | 47 | $0 (2024) |
| Lilly USA, LLC | $726.54 | 52 | $0 (2024) |
| GlaxoSmithKline, LLC. | $580.14 | 41 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $550.73 | 39 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $536.24 | 48 | $0 (2024) |
| Abbott Laboratories | $455.85 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,904 | 113 | AstraZeneca Pharmaceuticals LP ($261.98) |
| 2023 | $1,563 | 93 | ABBVIE INC. ($225.22) |
| 2022 | $1,568 | 86 | Novo Nordisk Inc ($411.72) |
| 2021 | $1,147 | 79 | AstraZeneca Pharmaceuticals LP ($245.60) |
| 2020 | $1,008 | 73 | Novo Nordisk Inc ($278.24) |
| 2019 | $1,429 | 117 | PFIZER INC. ($269.61) |
| 2018 | $1,400 | 115 | PFIZER INC. ($374.72) |
| 2017 | $2,745 | 244 | Novo Nordisk Inc ($392.17) |
All Payment Transactions
920 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardio-renal | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.50 | General |
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Bone Health | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.50 | General |
| 11/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: VACCINES | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $24.84 | General |
| Category: NEUROLOGY | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Diabetes Care | ||||||
| 11/01/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Bone Health | ||||||
| 10/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Oncology | ||||||
| 10/24/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: PAIN | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,723 | 2,796 | $496,876 | $107,832 |
| 2022 | 23 | 1,890 | 3,071 | $341,554 | $103,568 |
| 2021 | 25 | 2,312 | 3,452 | $341,944 | $156,588 |
| 2020 | 25 | 1,765 | 2,931 | $280,168 | $112,514 |
Total Patients
7,690
Total Services
12,250
Medicare Billing
$480,503
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 498 | 931 | $235,543 | $40,921 | 17.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 41 | 41 | $17,724 | $11,560 | 65.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 192 | 192 | $49,728 | $9,588 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 284 | 355 | $63,545 | $9,304 | 14.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 112 | 113 | $9,711 | $8,050 | 82.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 47 | 48 | $26,352 | $3,691 | 14.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 123 | 124 | $8,804 | $3,689 | 41.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 47 | 47 | $15,557 | $3,600 | 23.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 53 | 61 | $24,827 | $3,520 | 14.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 64 | 69 | $8,970 | $2,828 | 31.5% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 25 | 362 | $10,136 | $2,653 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 25 | $8,925 | $1,706 | 19.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $3,641 | $1,674 | 46.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 43 | 43 | $3,053 | $1,279 | 41.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 39 | 42 | $3,486 | $969.40 | 27.8% |
| 85610 | Blood test, clotting time | Office | 2023 | 23 | 230 | $2,530 | $966.00 | 38.2% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 13 | 16 | $1,463 | $804.48 | 55.0% |
| 74022 | X-ray series of abdomen with single x-ray of chest | Office | 2023 | 12 | 12 | $1,488 | $470.88 | 31.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 11 | 11 | $363.00 | $240.90 | 66.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 44 | 47 | $470.00 | $160.27 | 34.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 16 | $560.00 | $158.76 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 551 | 902 | $158,761 | $44,618 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 322 | 399 | $46,899 | $13,214 | 28.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 161 | 161 | $27,881 | $8,349 | 29.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 76 | 89 | $25,683 | $6,843 | 26.6% |
About Dr. Dann Fredrickson, MD
Dr. Dann Fredrickson, MD is a Internal Medicine healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1215934203.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dann Fredrickson, MD has received a total of $12,766 in payments from pharmaceutical and medical device companies, with $1,904 received in 2024. These payments were reported across 920 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($12,660).
As a Medicare-enrolled provider, Fredrickson has provided services to 7,690 Medicare beneficiaries, totaling 12,250 services with total Medicare billing of $480,503. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Kansas City, MO
- Active Since 07/05/2005
- Last Updated 09/26/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1215934203
Products in Payments
- FARXIGA (Drug) $1,038
- Ozempic (Drug) $770.12
- VRAYLAR (Drug) $562.99
- Victoza (Drug) $561.51
- XARELTO (Drug) $413.37
- Rybelsus (Drug) $361.18
- EVENITY (Biological) $356.83
- BREZTRI (Drug) $354.00
- CHANTIX (Drug) $347.51
- JARDIANCE (Drug) $343.00
- Vascepa (Drug) $321.85
- FREESTYLE LIBRE 3 (Device) $295.33
- ELIQUIS (Drug) $262.88
- MOUNJARO (Drug) $240.89
- Movantik (Drug) $207.23
- ENTRESTO (Drug) $202.64
- LYRICA (Drug) $198.87
- NURTEC ODT (Drug) $192.98
- VIAGRA (Drug) $182.10
- Prolia (Biological) $180.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kansas City
James O'keefe, Md, MD
Internal Medicine — Payments: $834,178
Internal Medicine $834,178
Shadi Hamdeh, Md, MD
Internal Medicine — Payments: $623,244
Internal Medicine $623,244
Dr. Patrick Moriarty, M.d, M.D
Internal Medicine — Payments: $618,967
Internal Medicine $618,967
Gerald Mancuso, M.d, M.D
Internal Medicine — Payments: $615,894
Internal Medicine $615,894
Dr. Ryan Taylor, M.d, M.D
Internal Medicine — Payments: $512,094
Internal Medicine $512,094
Sanjaya Gupta, Md, MD
Internal Medicine — Payments: $325,155
Internal Medicine $325,155